摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[2,2-二溴-1-(4-乙氧基苯基)乙基]-4-乙氧基苯 | 7388-30-9

中文名称
1-[2,2-二溴-1-(4-乙氧基苯基)乙基]-4-乙氧基苯
中文别名
——
英文名称
1,1-bis-(4-ethoxy-phenyl)-2,2-dibromo-ethane
英文别名
1,1-Bis-(4-aethoxy-phenyl)-2,2-dibrom-aethan;Benzene, 1,1'-(2,2-dibromoethylidene)bis(4-ethoxy-;1-[2,2-dibromo-1-(4-ethoxyphenyl)ethyl]-4-ethoxybenzene
1-[2,2-二溴-1-(4-乙氧基苯基)乙基]-4-乙氧基苯化学式
CAS
7388-30-9
化学式
C18H20Br2O2
mdl
——
分子量
428.164
InChiKey
IFSJHPZRUVDPCT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    104 °C
  • 沸点:
    438.9±45.0 °C(Predicted)
  • 密度:
    1.457±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    22
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    18.5
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:f93d89fca8e100a7a5d7c4077610736d
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • In vitro antimicrobial susceptibilities of three Porphyromonas spp and in vivo responses in the oral cavity of cats to selected antimicrobial agents
    作者:JM NORRIS、DN LOVE
    DOI:10.1111/j.1751-0813.2000.tb11895.x
    日期:2000.8
    ObjectivesTo determine in vitro susceptibility ofPorphyromonas gingivalis, P salivosaandP circumdentariato seven antimicrobial agents by agar dilution and Epsilometer test methods and to assess the effectiveness of these antimicrobial agents in reducing the numbers of eachPorphyromonasspp in the oral cavity of 16 domestic cats.DesignA two‐part prospective study involving in vitro antimicro‐bial studies usingPorphyromonasspp obtained from naturally occurring feline infections and in vivo antimicrobial response studies using client‐owned cats with naturally occurring periodontal disease.ProcedureIsolates (n = 25) of three felinePorphyromonasspp from the oral cavity and oral‐associated disease were tested for their in vitro susceptibility to amoxycillin, amoxycillin‐clavulanate, benzylpenicillin, clindamycin, doxycycline, erythromycin and metronidazole, using agar dilution and Epsilometer test methods. Digoxigenin‐labelled whole chromosomal DNA probes directed againstP gingivalis VPB3492,P circumdentariaNCTC 12469TandP salivosaVPB 3313 were used to quantify organisms taken from two sample sites at the gingival margins of these cats prior to, and 5 days after, treatment with one of four commonly used antimicrobial products (amoxycillin‐clavulanate, clindamycin, doxycycline or spiramycin‐metronidazole). The response to treatment was assessed clinically for each cat.ResultsAll isolates were susceptible in vitro to all seven antimicrobial agents using both methods. The numbers ofP gingivaliswere not reduced at the gingival sample sites by administration of amoxycillin‐clavulanate for 5 days, although this treatment reduced the numbers ofP salivosaandP circumdentaria tobelow detection levels in six of eight and two of three of sample sites, respectively; clinical improvement was not observed in cats treated with amoxycillin‐clavulanate. Treatment with clindamycin, doxycycline or spiramycin‐metronidazole resulted in clinical improvement and a marked reduction of allPorphyromonasisolates at the sample sites.ConclusionThe Epsilometer test is a simple and accurate method for determining the minimum inhibitory concentration forP gingivalis, P salivosaandP circumdentaria.All strains were susceptible in vitro to all the antimicrobial agents tested, although clinical improvement of gingival disease was not noted with amoxycillin‐clavulanate when given for 5 days at usual doses. This appears to be the first report of the disparity between the in vivo and in vitro susceptibility of oral bacterial strains to amoxycillin‐clavulanate in the veterinary dental literature. This also appears to be the first report in which clinical and microbiological responses to commonly used antimicrobial agents for periodontal disease in cats has been documented and quantified. It was shown that treatment with clindamycin, spiramycin‐metronidazole or doxycycline not only produced a substantial reduction in the number ofPorphyromonasspp (in the majority of cases to below detection levels), but also resulted in substantial clinical improvement. This would indicate that these antimicrobial agents are useful adjunctive therapy to mechanical debridement in domestic cats.
  • Harris; Frankforter, Journal of the American Chemical Society, 1926, vol. 48, p. 3148
    作者:Harris、Frankforter
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐